Online inquiry

IVTScrip™ mRNA-Human ABHD6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10571MR)

This product GTTS-WK10571MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABHD6 protein. This product can be used in Primitive endoderm cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001320126.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 57406
UniProt ID Q9BV23
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABHD6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10571MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK4115MR IVTScrip™ mRNA-Human PKC-alpha, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA PKC-alpha
GTTS-WK11319MR IVTScrip™ mRNA-Human ADCY1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADCY1
GTTS-WK3901MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK13418MR IVTScrip™ mRNA-Human ADCK5, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADCK5
GTTS-WK18701MR IVTScrip™ mRNA-Human ALDH3B1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ALDH3B1
GTTS-WK15761MR IVTScrip™ mRNA-Human AMT, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AMT
GTTS-WK17970MR IVTScrip™ mRNA-Human AOC4P, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AOC4P
GTTS-WK21875MR IVTScrip™ mRNA-Human ATP11A, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ATP11A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW